ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013

Preventive Services Task Force Urges Colorectal Cancer Screening for 50 and Up; Advises Against Tamoxifen for Women at Low to Average Breast Cancer Risk

July 19, 2002

In Brief: NCAB Schedules Full Day Of AIDS Discussion; PBS To Show Documentary On Tobacco Issues

November 6, 1987

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

Hormone Therapy At Menopause Linked to More Breast Cancer Risk

February 25, 2011